User profiles for F. Nigim

Fares Nigim MD PhD

Massachusetts General Hospital / Dana Farber Cancer Institute- Harvard
Verified email at dfci.harvard.edu
Cited by 858

[PDF][PDF] Extreme vulnerability of IDH1 mutant cancers to NAD+ depletion

…, JRJ Yeh, WT Curry, D Zhao, S Sundaram, F Nigim… - Cancer cell, 2015 - cell.com
Heterozygous mutation of IDH1 in cancers modifies IDH1 enzymatic activity, reprogramming
metabolite flux and markedly elevating 2-hydroxyglutarate (2-HG). Here, we found that 2-…

[HTML][HTML] Emerging medical treatments for meningioma in the molecular era

F Nigim, H Wakimoto, EM Kasper, L Ackermans… - Biomedicines, 2018 - mdpi.com
Meningiomas are the most common type of primary central nervous system tumors.
Approximately, 80% of meningiomas are classified by the World Health Organization (WHO) as …

[HTML][HTML] AS1411-induced growth inhibition of glioma cells by up-regulation of p53 and down-regulation of Bcl-2 and Akt1 via nucleolin

Y Cheng, G Zhao, S Zhang, F Nigim, G Zhou, Z Yu… - PLoS …, 2016 - journals.plos.org
… (f) Immunofluorescence detection of the expression and location of NCL in U87 and NHA
cells. (g) Immunofluorescence detection of FITC-AS1411 (green) and NCL (red) co-…

Diagnostic accuracy of PET, SPECT, and arterial spin-labeling in differentiating tumor recurrence from necrosis in cerebral metastasis after stereotactic radiosurgery

…, D Hackney, PC Warnke, F Nigim… - American Journal …, 2015 - Am Soc Neuroradiology
BACKGROUND AND PURPOSE: Radiographic assessment of cerebral metastasis after
stereotactic radiosurgery remains a major challenge in neuro-oncology. It is often difficult to …

[HTML][HTML] Role of ventriculoperitoneal shunting in patients with neoplasms of the central nervous system: an analysis of 59 cases

F Nigim, JF Critchlow… - Molecular and …, 2015 - spandidos-publications.com
Approximately 1-5% of patients with cerebral metastasis and~ 40% of patients with primary
brain tumors suffer from hydrocephalus. These patients often exhibit a poor prognosis. The …

Blockade of transforming growth factor‐β signaling enhances oncolytic herpes simplex virus efficacy in patient‐derived recurrent glioblastoma models

S Esaki, F Nigim, E Moon, S Luk… - … journal of cancer, 2017 - Wiley Online Library
Despite the current standard of multimodal management, glioblastoma (GBM) inevitably
recurs and effective therapy is not available for recurrent disease. A subset of tumor cells with …

Multidisciplinary management improves survival at 1 year after surgical treatment for non-small-cell lung cancer: a propensity score-matched study

…, A Frassoldati, I Santi, R Rinaldi, F Nigim… - European Journal of …, 2018 - academic.oup.com
OBJECTIVES The management of patients affected by lung cancer requires the expertise of
specialists from different disciplines. Although the advantages of multidisciplinary team …

Targeting hypoxia-inducible factor 1α in a new orthotopic model of glioblastoma recapitulating the hypoxic tumor microenvironment

F Nigim, J Cavanaugh, AP Patel… - … of Neuropathology & …, 2015 - academic.oup.com
… Arrows point to blood vessels (F). CD34 staining reveals tortuous and dilated vasculature
at the tumor periphery in the xenografts ( G , left panel). CD31 staining of the patient section …

A new patient-derived orthotopic malignant meningioma model treated with oncolytic herpes simplex virus

F Nigim, S Esaki, M Hood, N Lelic, MF James… - Neuro …, 2016 - academic.oup.com
Background Higher-grade meningiomas (HGMs; World Health Organization grades II and III)
pose a clinical problem due to high recurrence rates and the absence of effective therapy. …

Granular cell tumor of the infundibulum: a systematic review of MR-radiography, pathology, and clinical findings

JB Polasek, Y Laviv, F Nigim, R Rojas… - Journal of Neuro …, 2018 - Springer
Introduction Granular cell tumors (GCTs) of the infundibulum are rare in practice and literature,
resulting in a lack of evidence-based standard of care. We present two characteristic …